1
Material Type:
Artigo de Jornal
Chagas Disease (T. cruzi Infection) Epidemiological Review and Competitive Landscape Analysis 2024-2028
PR newswire, 2024-02-08
PR Newswire Association LLC
Sem texto completo
2
Material Type:
Artigo de Jornal
GHIT Fund Announces New Investments: A Total of 230 Million Yen in Drugs for Malaria and Chagas Disease
PR newswire, 2020-12-08
PR Newswire Association LLC
Sem texto completo
3
Material Type:
Artigo de Jornal
Investment of Approximately USD 8.8 Million for New Drug Development Against Malaria to Partners Including Marubeni and Eisai
PR newswire, 2023-12-13
PR Newswire Association LLC
Sem texto completo
4
Material Type:
Artigo de Jornal
MarketVIEW - Chagas disease vaccines
PR newswire, 2014-07-07
PR Newswire Association LLC
Sem texto completo
5
Material Type:
Artigo de Jornal
VETERINARY COLLEGE'S ROGER RAMIREZ-BARRIOS RECEIVES ZOETIS RESEARCH AWARD
States News Service, 2023-12-05
States News Service
Sem texto completo
6
Material Type:
Artigo de Jornal
FRIDAY IS WORLD CHAGAS DISEASE DAY
States News Service, 2023-04-14
States News Service
Sem texto completo
7
Material Type:
Artigo de Jornal
Small Australian Research Team Yields Big Results Towards Finding a Cure for Chagas Disease
PR newswire, 2010-12-01
PR Newswire Association LLC
Sem texto completo
8
Material Type:
Artigo de Jornal
Texas Children's Hospital Center for Vaccine Development awarded grant to develop therapeutic vaccine for Chagas disease
PR newswire, 2015-07-28
PR Newswire Association LLC
Sem texto completo
9
Material Type:
Artigo de Jornal
GHIT Fund Announces New Investments: A Total of 750 Million Yen in Drugs for Malaria and Chagas Disease, Vaccine for Malaria, and Diagnostics for Tuberculosis
PR newswire, 2021-11-04
PR Newswire Association LLC
Sem texto completo
10
Material Type:
Artigo de Jornal
As the GHIT Fund Closes Out First Five Years of RD for Lifesaving Medical Breakthroughs, It Launches Next Phase, Focusing on Access and Delivery, Bringing Total Investment to 13.2 Billion Yen (US$123 Million)
PR newswire, 2018-03-28
PR Newswire Association LLC
Sem texto completo